LEVELS OF EXPRESSION OF CD31+, CD3+, CD20+ IMMUNOHISTOCHEMICAL MARKERS IN ADRENAL GLAND TISSUE IN COVID-19

CD31+, CD3+, CD20+ immunohistochemical markers were studied in the adrenal gland tissue in order to study the degree of damage to the adrenal gland caused by COVID-19 infection and the immunological response of the organ against the virus.

Publication Details

Journal: Zenodo (CERN European Organization for Nuclear Research)
Published: 2024-10-25
DOI: https://doi.org/10.5281/zenodo.13989531
Primary Topic: Adrenal Hormones and Disorders
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

LEVELS OF EXPRESSION OF CD31+, CD3+, CD20+ IMMUNOHISTOCHEMICAL MARKERS IN ADRENAL GLAND TISSUE IN COVID-19

Oct 25, 2024

Zenodo (CERN European Organization for Nuclear Research)

Adrenal Hormones and Disorders

article

LEVELS OF EXPRESSION OF CD31+, CD3+, CD20+ IMMUNOHISTOCHEMICAL MARKERS IN ADRENAL GLAND TISSUE IN COVID-19

October 25, 2024article en

Abstract

Zenodo (CERN European Organization for Nuclear Research)

Good health and well-being

Openalex Percentile: Top 51%

Adrenal Hormones and Disorders

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

LEVELS OF EXPRESSION OF CD31+, CD3+, CD20+ IMMUNOHISTOCHEMICAL MARKERS IN ADRENAL GLAND TISSUE IN COVID-19 · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS